Fig. 6: Analysis of genomic events of clinical samples.
From: Clinical and analytical validation of a combined RNA and DNA exome assay across a large tumor cohort
Major genomic findings for oncogenes and tumor suppressors across solid cancers (n = 1399). Frequency thresholds for color code: 0.2 for somatic SNVs/INDELs, 0.2 for CNVs, 0.05 for fusion events, 0.03 for clinically pertinent germline variants. Intronic and silent variants were filtered out for SNVs/INDELs.
